Corporate Advisory

PharmaDeals v4

PharmaTelevision

Industry Insight and Intelligence

 

PTV Latest

Cancer Research Technology: Keith Blundy on Collaborating with Big Pharma

More
Image of woman with pen

Register for E-Mail Updates

Email Address
Submit

Keeping You Updated

Roche:Genentech Integration Latest: Exclusive Interview on PharmaTelevision

Oxford, UK (PRWEB) June 4, 2009 - PharmaTelevision announced today that it is to broadcast an exclusive interview with Dan Zabrowski, Global Head, Pharma Partnering, Roche Pharmaceuticals Division and Joe McCracken, Vice President, Business Development, Genentech, on the Roche:Genentech integration, on June 4th 2009.

The interview on the business TV show “PharmaVentures Business Review” reveals the new structure and position for Genentech in the Roche organisation and how companies wishing to partner with Roche or Genentech can do so in the future. The interview also discusses broader issues such as the future position of Genentech and its role moving forwards.

Dr Fintan Walton, CEO of PharmaVentures, who also presents the PharmaTelevision shows and interviewed both Zabrowski and McCracken, said: “This exclusive interview provides insight into the operations of one of the world’s largest pharmaceutical companies. We are delighted that Roche used PharmaTelevision to communicate its integration strategy and how its implementation is progressing”.

PharmaTelevision® (www.pharmatelevision.com) is the groundbreaking online TV channel for the pharmaceutical and biotech sector, offering insight and featured interviews with industry leaders every week. Since May 2006, PharmaTelevision has rapidly grown and the channel now boasts over 200 TV programmes with a truly global audience, 60% of whom are C-suite executives. In 2008, the channel launched a sleek new look and introduced two exciting TV programmes – the Financial Report and the Regional Report, which, together with our well-established TV programmes, help to give our viewers a complete overview of industry trends, analysis including deals, investments and strategic policies within the sector. In 2009, PharmaTelevision will be launching PTV News – a daily summary and analysis of the major news headlines, ensuring that, wherever in the world they are, our audience can stay truly informed.

PharmaTelevision is a media division of PharmaVentures Ltd (www.pharmaventures.com).

For further information please contact: Fiona Bishop, +44 (0) 1865 784 187 or e-mail fiona@pharmatelevision.com

- ends -

Note to Editors

PharmaVentures Limited (http://www.pharmaventures.com) is a leading international corporate advisory firm supporting its clients' growth ambitions in the health care industry. It has considerable experience and expertise in the field of tangible and intangible transactions, providing advice at both a strategic level, as well as acting as advisor and broker at an implementation level. Its transactional experience includes licensing, joint ventures, mergers, acquisitions and divestments. Its clients are worldwide, including Europe, the USA and AsiaPacific. Clients range from start-ups to global pharmaceutical corporations, diversified industrial corporations, investment houses and government bodies. Its subsidiary PharmaTelevision produces the highly popular PharmaDeals® range of intelligence products including analysis tools and reports as well as the world's first dedicated online pharmaceutical television channel PharmaTelevision® (http://www.pharmatelevision.com).

Now in its 18th year, PharmaVentures is based in Oxford, UK, and employs over 30 people.